The assessment made available on the MyEasyPeptides website does not create a doctor-patient relationship between the individual completing the assessment and MyEasyPeptides. MyEasyPeptides-affiliated clinicians and medical providers, who adhere to rigorous medical protocols designed for patient safety, have established exclusionary criteria to determine if an individual does not qualify for peptide therapy or GLP-1 medication. The answers an individual provides to the MyEasyPeptides assessment consequently determine if the individual is screened out of eligibility for medication, and a MyEasyPeptides clinician will meet with an individual after checkout to determine if they qualify for a prescription. MyEasyPeptides clinicians retain the decision to prescribe compounded peptides and GLP-1s to patients.

All claims and benefits on this website refer to self-reported data from customers on a treatment plan that includes compounded peptide medications and consultations with medical professionals. Customers reported their metrics on their initial medical intake questionnaire every 3-4 weeks thereafter. Results from compounded medications found on the MyEasyPeptides platform may vary and be affected by an individual's adherence to the program and their clinician's recommendations. Compounded peptides and GLP-1s are produced in FDA-regulated 503A compounding facilities. Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider's medical judgment, which is informed by a telehealth consultation and medical history.

We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of compounded medication. MyEasyPeptides does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.

Pharmacy Providers

We are partnered with multiple USA certified 503A pharmacies to bring the best product and overall experience to our membership. Our team meets regularly with pharmacies to discuss any product shortages, shipping delays, and get updated reports on their medication testing.

Results vary based on starting weight and program adherence. Inches lost from hips, waist, chest, thighs, and arms in the first month. Patients exercised daily and ate a reduced-calorie diet. Their fat loss is not typical. Results may vary. Medication prescriptions are at the discretion of medical providers and may not be suitable for everyone. MyEasyPeptides patients typically result in steady weight loss after 4 weeks, involving a healthy diet and exercise changes. Consult a healthcare professional before using medication or starting any weight loss program.

Medication is included in the cost of the MyEasyPeptides Program. The trademarks, service marks, trade names, and products displayed on this Internet site are protected and belong to their respective owners. Medical treatment is provided by licensed medical providers and affiliated professional entities. No data, photos, claims, or any other information is associated with results derived from clinical trials, studies, or public information and is always representative of the MyEasyPeptides patient experience.

Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies. No representation or warranty is made regarding the accuracy, completeness, or reliability of such content. Individuals appearing in advertisements may be actors or models.

Testimonials on the website are from MyEasyPeptides patients. For patient privacy, images representing those testimonials may use models.

By accepting our Terms of Use, you additionally understand and agree that MyEasyPeptides is not acting as a pharmacy, nor does MyEasyPeptides control or interfere with any such services.

Stay Connected!

Terms of Use

Pharmacy Providers